Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 19/01/2011
PIL Ketalar Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 13/01/2010 and displayed until 19/01/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to storage instructions
Updated on 05/06/2009 and displayed until 13/01/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 29/01/2009 and displayed until 05/06/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/12/2008 and displayed until 29/01/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/04/2006 and displayed until 05/12/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to packaging
  • Change to storage instructions
Updated on 19/09/2003 and displayed until 05/04/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   ketamine hydrochloride